Cannabinoid Receptors

GAT228 View larger

GAT228

AOBS1952

CAS No: 1446648-15-2 

Chemical Name: 3-[(1R)-2-nitro-1-phenylethyl]-2-phenyl-1H-Indole, R-(+)-3-(2-Nitro-1-phenylethyl)-2-phenyl-1H-indole  

More details

Molarity Calculation Cart®

HOW TO ORDER

$29.50

$29.50 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $13.28 Total: $1,327.50
150 $15.34 Total: $767.00
125 $18.00 Total: $449.88
110 $21.24 Total: $212.40
15 $25.08 Total: $125.38

Data sheet

Molecular FormulaC22H18N2O2
Molecular Weight342.39
CAS Numbers1446648-15-2
Storage Condition0°C (short term), -20°C (long term), desiccated
SolubilityDMSA: 25 mg/mL
Purity98% by HPLC

More info

The R-(+)-enantiomer of GAT211, a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling that was found to amplify the therapeutic effect of endocannabinoids without the negative side effects of psychoactivity or tolerance. GAT228 was found to be an unbiased CB1 allosteric agonist, while the S-(-)-enantiomer, GAT229,was found to be a potent, Gαi/o-biased CB1 PAM without intrinsic activity. In radioligand binding assays, both GAT228 and GAT229 behaved as PAMs of orthosteric ligand binding. Allosteric CB1R activation by GAT211 and its enantiomers could be a better therapeutic strategy for enhancing endogenous cannabinergic activity than targeting endocannabinoid-degrading enzymes with small-molecule inhibitors, with a lower likelihood of tolerance and dependence.